Alverno Laboratories and Ibex Medical Analytics have announced a deal to deploy Ibex's artificial intelligence (AI)-powered Galen software to help pathologists provide diagnosis and care for cancer patients.
Ibex received breakthrough device approval from the U.S. Food and Drug Administration for the Galen software in June. The application is designed to improve the quality of cancer diagnosis, implement real-time quality control, reduce diagnosis time, and boost productivity, the companies said.
Alverno is one of the largest pathology laboratories in the Midwest, managing 32 hospital laboratories. It provides laboratory services to thousands of physician offices.